Lab
Solano Martinez, Yanira
Solano Martinez, Yanira was paid $531K by Medicaid between Feb 2018 and Dec 2024, across 37 billing codes. Its largest line is 84443, Thyroid stimulating hormone (TSH) — 17% of everything it billed.
33Billing provider infoSOLANO MARTINEZ, YANIRA
CAGUAS, PR 00725
CAGUAS, PR 00725
33aNPI1902064066assigned 05/27/2008
33bProvider typeClinical Medical Laboratory
28Total paid$531K
24GClaims44,321
24DCodes billed37
24AFirst – last monthFeb 2018 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Puerto Rico
Rank by total paid#240 of 777
Median peer was paid$278K
This provider vs. median1.9×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 375 | $3K | |
| 2019 | 859 | $6K | |
| 2020 | 2,838 | $31K | |
| 2021 | 8,746 | $117K | |
| 2022 | 10,592 | $141K | |
| 2023 | 8,857 | $98K | |
| 2024incomplete | 12,054 | $134K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 84443 | Thyroid stimulating hormone (TSH) | 17% | 4,637 | 3,970 | $91K |
| 80061 | Lipid panel | 14% | 4,709 | 3,970 | $77K |
| 80053 | Comprehensive metabolic panel | 12% | 5,165 | 4,317 | $66K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 8.3% | 1,672 | 1,458 | $44K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 8.2% | 6,242 | 5,104 | $43K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 7.4% | 915 | 827 | $39K |
| 83036 | Hemoglobin; glycosylated (A1C) | 6.9% | 3,243 | 2,769 | $37K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 4.1% | 896 | 805 | $22K |
| 81000 | 3.9% | 5,485 | 4,515 | $21K | |
| 82274 | 2.2% | 810 | 730 | $11K | |
| 82043 | 1.7% | 1,772 | 1,508 | $9K | |
| 82570 | 1.6% | 1,886 | 1,605 | $9K |
25 more codes
| 84153 | 1.4% | 471 | $8K | |
| 87088 | 1.4% | 731 | $7K | |
| 84439 | 1.4% | 899 | $7K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.2% | 601 | $6K |
| 82607 | 1.0% | 398 | $5K | |
| 84436 | <1% | 766 | $5K | |
| 86701 | <1% | 507 | $4K | |
| 84479 | <1% | 627 | $4K | |
| 86803 | <1% | 262 | $3K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 214 | $3K |
| 86328 | <1% | 138 | $3K | |
| 86592 | <1% | 554 | $2K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 214 | $1K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 151 | $1K |
| 87205 | <1% | 145 | $551.22 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 12 | $513.30 |
| 87590 | <1% | 25 | $477.10 | |
| 87490 | <1% | 25 | $472.63 | |
| 85651 | <1% | 52 | $217.77 | |
| 80164 | <1% | 14 | $180.88 | |
| 82746 | <1% | 12 | $168.92 | |
| 85730 | <1% | 13 | $70.45 | |
| 85610 | <1% | 13 | $44.90 | |
| 3048F | 0% | 22 | $0.00 | |
| 3044F | 0% | 23 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.